The proton-pump inhibitor lansoprazole enhances amyloid beta production.
A key event in the pathogenesis of Alzheimer's disease (AD) is the accumulation of amyloid-β (Aβ) species in the brain, derived from the sequential cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. Based on a systems biology study to repurpose drugs for AD, we explore the...
Enregistré dans:
Auteurs principaux: | Nahuai Badiola, Victor Alcalde, Albert Pujol, Lisa-Marie Münter, Gerd Multhaup, Alberto Lleó, Mireia Coma, Montserrat Soler-López, Patrick Aloy |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/aaaf0f44a49646f28a9a25d4605314d4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The effectiveness and cost of lansoprazole and pantoprazole for stress ulcer prophylaxis in intensive care unit
par: Mega Octavia, et autres
Publié: (2021) -
Proton pumping accompanies calcification in foraminifera
par: Takashi Toyofuku, et autres
Publié: (2017) -
Gastric proton pump with two occluded K+ engineered with sodium pump-mimetic mutations
par: Kazuhiro Abe, et autres
Publié: (2021) -
A natural light-driven inward proton pump
par: Keiichi Inoue, et autres
Publié: (2016) -
Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations
par: Alai M, et autres
Publié: (2015)